Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA and patient's age

Gynecologic Oncology

Volumn 129, Issue 3, 2013, Pages 467-471

  Kondalsamy Chennakesavan, Srinivas ^a,b,c   Hackethal, Andreas ^a,d   Bowtell, David ^c   Obermair, Andreas ^a,d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF SOUTHERN QUEENSLAND   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Adnexal mass; CA 125; CEA; HE4; Ovarian cancer

Indexed keywords

CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; HUMAN EPIDIDYMIS PROTEIN 4; TUMOR MARKER;

ADULT; AGE; ARTICLE; BENIGN TUMOR; BLOOD SAMPLING; CANCER RISK; CANCER STAGING; DIAGNOSTIC VALUE; FEMALE; HIGH RISK POPULATION; HUMAN; OVARY CARCINOMA; OVARY TUMOR; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL;

AGE FACTORS; CA-125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN DISEASES; OVARIAN NEOPLASMS; PROSPECTIVE STUDIES; PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84877585369     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.03.001     Document Type: Article

References (33)

1. J.M. McDonald, and S.C. Modesitt The incidental postmenopausal adnexal mass Clin Obstet Gynecol 49 3 Sep 2006 506 516 [PubMed PMID: 16885657. Epub 2006/08/04. Eng]
2. P. Yip, T.H. Chen, P. Seshaiah, L.L. Stephen, K.L. Michael-Ballard, and J.P. Mapes Comprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkers PLoS One 6 12 2011 e29533 [PubMed PMID: 22216306. Pubmed Central PMCID: 3244467. Epub 2012/01/05. eng]
3. T. Van Gorp, J. Veldman, B. Van Calster, I. Cadron, K. Leunen, and F. Amant Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses Eur J Cancer 48 11 Jul 2012 1649 1656 [PubMed PMID: 22226481. Epub 2012/01/10. eng]
4. R.C. Bast Jr., M. Feeney, H. Lazarus, L.M. Nadler, R.B. Colvin, and R.C. Knapp Reactivity of a monoclonal antibody with human ovarian carcinoma J Clin Invest 68 5 Nov 1981 1331 1337 [PubMed PMID: 7028788. Pubmed Central PMCID: 370929. Epub 1981/11/01. eng]
5. T.I. Goonewardene, M.R. Hall, and G.J. Rustin Management of asymptomatic patients on follow-up for ovarian cancer with rising CA-125 concentrations Lancet Oncol 8 9 Sep 2007 813 821 [PubMed PMID: 17765190. Epub 2007/09/04. eng]
6. S. Paramasivam, L. Tripcony, A. Crandon, M. Quinn, I. Hammond, and D. Marsden Prognostic importance of preoperative CA-125 in International Federation of Gynecology and Obstetrics stage I epithelial ovarian cancer: an Australian multicenter study J Clin Oncol 23 25 Sep 1 2005 5938 5942 [PubMed PMID: 16087942. Epub 2005/08/10. eng]
7. M.T. Galgano, G.M. Hampton, and H.F. Frierson Jr. Comprehensive analysis of HE4 expression in normal and malignant human tissues Mod Pathol 19 6 Jun 2006 847 853 [PubMed PMID: 16607372. Epub 2006/04/12. eng]
8. C. Kirchhoff, I. Habben, R. Ivell, and N. Krull A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors Biol Reprod 45 2 Aug 1991 350 357 [PubMed PMID: 1686187]
9. R. Drapkin, H.H. von Horsten, Y. Lin, S.C. Mok, C.P. Crum, and W.R. Welch Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas Cancer Res 65 6 Mar 15 2005 2162 2169 [PubMed PMID: 15781627. Epub 2005/03/23. eng]
10. R.G. Moore, A.K. Brown, M.C. Miller, D. Badgwell, Z. Lu, and W.J. Allard Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus Gynecol Oncol 110 2 Aug 2008 196 201 [PubMed PMID: 18495222. Epub 2008/05/23. eng]
11. R.G. Moore, D.S. McMeekin, A.K. Brown, P. DiSilvestro, M.C. Miller, and W.J. Allard A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass Gynecol Oncol 112 1 Jan 2009 40 46 [PubMed PMID: 18851871. Epub 2008/10/15. eng]
12. J.M. Escudero, J.M. Auge, X. Filella, A. Torne, J. Pahisa, and R. Molina Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases Clin Chem 57 11 Nov 2011 1534 1544 [PubMed PMID: 21933899. Epub 2011/09/22. eng]
13. M. Montagnana, E. Danese, O. Ruzzenente, V. Bresciani, T. Nuzzo, and M. Gelati The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful? Clin Chem Lab Med 49 3 Mar 2011 521 525 [PubMed PMID: 21288178. Epub 2011/02/04. eng]
14. M. Schummer, C. Drescher, R. Forrest, S. Gough, J. Thorpe, and I. Hellstrom Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 Gynecol Oncol 125 1 Apr 2012 65 69 [PubMed PMID: 22155417. Pubmed Central PMCID: 3303992. Epub 2011/12/14. eng]
15. F. Li, R. Tie, K. Chang, F. Wang, S. Deng, and W. Lu Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and ca125 in predicting epithelial ovarian cancer: a meta-analysis BMC Cancer 12 2012 258 [PubMed PMID: 22712526. Pubmed Central PMCID: 3443004. Epub 2012/06/21. eng]
16. M.A. Merritt, A.C. Green, C.M. Nagle, and P.M. Webb Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer Int J Cancer 122 1 Jan 1 2008 170 176 [PubMed PMID: 17721999. Epub 2007/08/28. eng]
17. C.M. Nagle, J.E. Francis, A.E. Nelson, H. Zorbas, K. Luxford, and A. de Fazio Reducing time to diagnosis does not improve outcomes for women with symptomatic ovarian cancer: a report from the Australian Ovarian Cancer Study Group J Clin Oncol 29 16 Jun 1 2011 2253 2258 [PubMed PMID: 21537035. Epub 2011/05/04. eng]
18. R.W. Tothill, A.V. Tinker, J. George, R. Brown, S.B. Fox, and S. Lade Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome Clin Cancer Res 14 16 Aug 15 2008 5198 5208 [PubMed PMID: 18698038]
19. F. Hakansson, E.V. Hogdall, L. Nedergaard, L. Lundvall, S.A. Engelholm, and A.T. Pedersen Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass Acta Obstet Gynecol Scand 91 4 Apr 2012 496 502 [PubMed PMID: 22229703. Epub 2012/01/11. eng]
20. I. Jacobs, D. Oram, J. Fairbanks, J. Turner, C. Frost, and J.G. Grudzinskas A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer Br J Obstet Gynaecol 97 10 Oct 1990 922 929 [PubMed PMID: 2223684. Epub 1990/10/01. eng]
21. Y.N. Chia, D.E. Marsden, G. Robertson, and N.F. Hacker Triage of ovarian masses Aust N Z J Obstet Gynaecol 48 3 Jun 2008 322 328 [PubMed PMID: 18532966. Epub 2008/06/06. eng]
22. E. Bandiera, C. Romani, C. Specchia, L. Zanotti, C. Galli, and G. Ruggeri Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management Cancer Epidemiol Biomarkers Prev 20 12 Dec 2011 2496 2506 [PubMed PMID: 22028406. Pubmed Central PMCID: 3237732]
23. Y.M. Kim, D.H. Whang, J. Park, S.H. Kim, S.W. Lee, and H.A. Park Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population Clin Chem Lab Med 49 3 Mar 2011 527 534 [PubMed PMID: 21320028. Epub 2011/02/16. eng]
24. M. Lenhard, P. Stieber, L. Hertlein, A. Kirschenhofer, S. Furst, and D. Mayr The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses Clin Chem Lab Med 49 12 Dec 2011 2081 2088 [PubMed PMID: 21923475. Epub 2011/09/20. eng]
25. R. Molina, J.M. Escudero, J.M. Auge, X. Filella, L. Foj, and A. Torne HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases Tumour Biol 32 6 Dec 2011 1087 1095 [PubMed PMID: 21863264. Pubmed Central PMCID: 3195682. Epub 2011/08/25. eng]
26. G. Ruggeri, E. Bandiera, L. Zanotti, S. Belloli, A. Ravaggi, and C. Romani HE4 and epithelial ovarian cancer: comparison and clinical evaluation of two immunoassays and a combination algorithm Clin Chim Acta 412 15-16 Jul 15 2011 1447 1453 [PubMed PMID: 21557935. Epub 2011/05/12. eng]
27. F. Jacob, M. Meier, R. Caduff, D. Goldstein, T. Pochechueva, and N. Hacker No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting Gynecol Oncol 121 3 Jun 1 2011 487 491 [PubMed PMID: 21420727. Epub 2011/03/23. eng]
28. T. Van Gorp, I. Cadron, E. Despierre, A. Daemen, K. Leunen, and F. Amant HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm Br J Cancer 104 5 Mar 1 2011 863 870 [PubMed PMID: 21304524. Pubmed Central PMCID: 3048204. Epub 2011/02/10. eng]
29. L. Wu, Z.Y. Dai, Y.H. Qian, Y. Shi, F.J. Liu, and C. Yang Diagnostic value of serum human epididymis protein 4 (HE4) in ovarian carcinoma: a systematic review and meta-analysis Int J Gynecol Cancer 22 7 Sep 2012 1106 1112 [PubMed PMID: 22854652]
30. S. Yu, H.J. Yang, S.Q. Xie, and Y.X. Bao Diagnostic value of HE4 for ovarian cancer: a meta-analysis Clin Chem Lab Med 50 8 Aug 2012 1439 1446 [PubMed PMID: 22868811]
31. M.A. Karlsen, N. Sandhu, C. Hogdall, I.J. Christensen, L. Nedergaard, and L. Lundvall Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass Gynecol Oncol 127 2 Nov 2012 379 383 [PubMed PMID: 22835718. Epub 2012/07/28. eng]
32. K. Partheen, B. Kristjansdottir, and K. Sundfeldt Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass J Gynecol Oncol 22 4 Dec 2011 244 252 [PubMed PMID: 22247801. Pubmed Central PMCID: 3254843]
33. H. Zheng, and Y. Gao Serum HE4 as a useful biomarker in discriminating ovarian cancer from benign pelvic disease Int J Gynecol Cancer 22 6 Jul 2012 1000 1005 [PubMed PMID: 22426406]